TG Therapeutics Inc (TGTX)
14.25
+0.15
(+1.06%)
USD |
NASDAQ |
Apr 23, 16:00
14.27
+0.02
(+0.14%)
After-Hours: 20:00
TG Therapeutics Cash from Investing (TTM): -50.65M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -50.65M |
September 30, 2023 | 10.37M |
June 30, 2023 | 37.61M |
March 31, 2023 | 17.49M |
December 31, 2022 | -20.01M |
September 30, 2022 | -32.99M |
June 30, 2022 | -30.64M |
March 31, 2022 | -43.49M |
December 31, 2021 | -0.332M |
September 30, 2021 | -55.70M |
June 30, 2021 | -40.15M |
March 31, 2021 | -26.47M |
December 31, 2020 | -24.51M |
September 30, 2020 | 27.57M |
June 30, 2020 | 12.62M |
March 31, 2020 | 1.867M |
December 31, 2019 | -0.718M |
September 30, 2019 | -0.484M |
June 30, 2019 | -6.875M |
March 31, 2019 | -1.747M |
December 31, 2018 | 1.18M |
September 30, 2018 | -27.06M |
June 30, 2018 | -11.83M |
March 31, 2018 | -12.42M |
December 31, 2017 | -8.208M |
Date | Value |
---|---|
September 30, 2017 | 31.28M |
June 30, 2017 | 38.05M |
March 31, 2017 | 34.47M |
December 31, 2016 | 26.54M |
September 30, 2016 | 17.54M |
June 30, 2016 | 2.045M |
March 31, 2016 | -30.45M |
December 31, 2015 | -24.69M |
September 30, 2015 | -36.30M |
June 30, 2015 | -36.38M |
March 31, 2015 | -14.51M |
December 31, 2014 | -18.36M |
September 30, 2014 | -14.14M |
June 30, 2014 | -14.15M |
March 31, 2014 | -4.929M |
December 31, 2013 | -4.926M |
September 30, 2013 | -0.0033M |
June 30, 2013 | -0.0017M |
March 31, 2013 | -0.0014M |
December 31, 2012 | -0.0014M |
September 30, 2012 | 0.009M |
June 30, 2012 | 0.009M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.0104M |
September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-55.70M
Minimum
Sep 2021
37.61M
Maximum
Jun 2023
-11.87M
Average
-6.875M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Amicus Therapeutics Inc | 98.06M |
Geron Corp | -180.32M |
Editas Medicine Inc | -3.731M |
G1 Therapeutics Inc | 2.81M |
Mersana Therapeutics Inc | 119.88M |